These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8806679)

  • 1. Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase.
    Baasner S; von Melchner H; Klenner T; Hilgard P; Beckers T
    Oncogene; 1996 Sep; 13(5):901-11. PubMed ID: 8806679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
    Schiffer IB; Gebhard S; Heimerdinger CK; Heling A; Hast J; Wollscheid U; Seliger B; Tanner B; Gilbert S; Beckers T; Baasner S; Brenner W; Spangenberg C; Prawitt D; Trost T; Schreiber WG; Zabel B; Thelen M; Lehr HA; Oesch F; Hengstler JG
    Cancer Res; 2003 Nov; 63(21):7221-31. PubMed ID: 14612517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity.
    Yang HY; Yang H; Zhao R; Lee MH
    J Cell Biochem; 2006 May; 98(1):128-38. PubMed ID: 16365885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth.
    Zhang Y; Yang HY; Zhang XC; Yang H; Tsai M; Lee MH
    Oncogene; 2004 Sep; 23(42):7132-43. PubMed ID: 15273726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
    Lin X; Gelman IH
    Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models.
    Eger K; Hermes M; Uhlemann K; Rodewald S; Ortwein J; Brulport M; Bauer AW; Schormann W; Lupatsch F; Schiffer IB; Heimerdinger CK; Gebhard S; Spangenberg C; Prawitt D; Trost T; Zabel B; Sauer C; Tanner B; Kolbl H; Krugel U; Franke H; Illes P; Madaj-Sterba P; Bockamp EO; Beckers T; Hengstler JG
    Biochem Biophys Res Commun; 2004 Oct; 323(3):979-86. PubMed ID: 15381096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.
    Al Moustafa AE; Foulkes WD; Wong A; Jallal H; Batist G; Yu Q; Herlyn M; Sicinski P; Alaoui-Jamali MA
    Oncogene; 2004 Jul; 23(30):5252-6. PubMed ID: 15229656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
    Kröger A; Dallügge A; Kirchhoff S; Hauser H
    Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplastic transformation and tumorigenesis associated with overexpression of IMUP-1 and IMUP-2 genes in cultured NIH/3T3 mouse fibroblasts.
    Ryoo ZY; Jung BK; Lee SR; Kim MO; Kim SH; Kim HJ; Ahn JY; Lee TH; Cho YH; Park JH; Kim JK
    Biochem Biophys Res Commun; 2006 Oct; 349(3):995-1002. PubMed ID: 16962562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells.
    Al Moustafa AE; Foulkes WD; Benlimame N; Wong A; Yen L; Bergeron J; Batist G; Alpert L; Alaoui-Jamali MA
    Oncogene; 2004 Jan; 23(2):350-8. PubMed ID: 14724563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
    Panet R; Marcus M; Atlan H
    J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tetracycline-responsive promoter system reveals the role of a secreted binding protein for FGFs during the early phase of tumor growth.
    Liaudet-Coopman ED; Schulte AM; Cardillo M; Wellstein A
    Biochem Biophys Res Commun; 1996 Dec; 229(3):930-7. PubMed ID: 8954996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
    Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.